Skip to main content
Second trimester inflammatory and metabolic markers in women delivering preterm with and without preeclampsia.
- Author(s): Ross, Kharah M;
- Baer, Rebecca J;
- Ryckman, Kelli;
- Feuer, Sky K;
- Bandoli, Gretchen;
- Chambers, Christina;
- Flowers, Elena;
- Liang, Liang;
- Oltman, Scott;
- Dunkel Schetter, Christine;
- Jelliffe-Pawlowski, Laura
- et al.
Published Web Locationhttps://doi.org/10.1038/s41372-018-0275-8
ObjectiveInflammatory and metabolic pathways are implicated in preterm birth and preeclampsia. However, studies rarely compare second trimester inflammatory and metabolic markers between women who deliver preterm with and without preeclampsia.
Study designA sample of 129 women (43 with preeclampsia) with preterm delivery was obtained from an existing population-based birth cohort. Banked second trimester serum samples were assayed for 267 inflammatory and metabolic markers. Backwards-stepwise logistic regression models were used to calculate odds ratios.
ResultsHigher 5-α-pregnan-3β,20α-diol disulfate, and lower 1-linoleoylglycerophosphoethanolamine and octadecanedioate, predicted increased odds of preeclampsia.
ConclusionsAmong women with preterm births, those who developed preeclampsia differed with respect metabolic markers. These findings point to potential etiologic underpinnings for preeclampsia as a precursor to preterm birth.
For improved accessibility of PDF content, download the file to your device.